• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用定量构效关系预测酸性药物的稳态分布容积。

Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships.

机构信息

Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

出版信息

J Pharm Sci. 2012 Mar;101(3):1253-66. doi: 10.1002/jps.22819. Epub 2011 Dec 13.

DOI:10.1002/jps.22819
PMID:22170307
Abstract

The volume of distribution (VD) is one of the most important pharmacokinetic parameters of drugs. The present study employs quantitative structure-pharmacokinetics relationships (QSPkR) to derive models for VD prediction of acidic drugs. The steady-state volume of distribution (VD(ss)) values of 132 acidic drugs were collected, the chemical structures were described by 178 molecular descriptors, and QSPkR models were derived after variable selection by genetic algorithm and stepwise regression. Models were validated by cross-validation procedures and external test set. According to the molecular descriptors selected as the most predictive for VD(ss), the presence of seven- and nine-member cycles, atom type P(5+), SH groups, and large nonionized substituents increase the VD(ss), whereas atom types S(2+) and S(4+) and polar ionized substituents decrease it. Cross-validation and external validation studies on the QSPkR models derived in the present study showed good predictive ability with mean fold error values ranging from 1.58 (cross-validation) to 2.25 (external validation). The model performance is comparable to more complicated methods requiring in vitro or in vivo experiments and superior to the existing QSPkR models concerning acidic drugs. Apart from the prediction of VD in human, present models are also useful as a curator of available pharmacokinetic databases.

摘要

分布容积(VD)是药物最重要的药代动力学参数之一。本研究采用定量构效关系(QSPkR)来建立预测酸性药物 VD 的模型。收集了 132 种酸性药物的稳态分布容积(VD(ss))值,用 178 个分子描述符描述其化学结构,通过遗传算法和逐步回归进行变量选择后得出 QSPkR 模型。通过交叉验证程序和外部测试集对模型进行验证。根据所选的最能预测 VD(ss)的分子描述符,存在七元和九元环、原子类型 P(5+)、SH 基团和大的非电离取代基会增加 VD(ss),而原子类型 S(2+)和 S(4+)和极性电离取代基则会降低 VD(ss)。本研究中得出的 QSPkR 模型的交叉验证和外部验证研究表明,其具有良好的预测能力,平均折叠误差值范围为 1.58(交叉验证)至 2.25(外部验证)。该模型的性能与需要进行体外或体内实验的更复杂方法相当,并且优于现有的关于酸性药物的 QSPkR 模型。除了预测人体中的 VD 外,目前的模型还可用作可用药代动力学数据库的管理员。

相似文献

1
Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships.应用定量构效关系预测酸性药物的稳态分布容积。
J Pharm Sci. 2012 Mar;101(3):1253-66. doi: 10.1002/jps.22819. Epub 2011 Dec 13.
2
Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution.定量构效关系建模:分布表观容积
J Pharm Pharmacol. 2004 Mar;56(3):339-50. doi: 10.1211/0022357022890.
3
QSPR models for the prediction of apparent volume of distribution.用于预测表观分布容积的定量构效关系模型。
Int J Pharm. 2006 Aug 17;319(1-2):82-97. doi: 10.1016/j.ijpharm.2006.03.043. Epub 2006 Apr 7.
4
Quantitative structure--plasma protein binding relationships of acidic drugs.酸性药物的定量结构-血浆蛋白结合关系。
J Pharm Sci. 2012 Dec;101(12):4627-41. doi: 10.1002/jps.23303. Epub 2012 Sep 7.
5
Quantitative Structure - Pharmacokinetics Relationships Analysis of Basic Drugs: Volume of Distribution.碱性药物的定量构效关系 - 药代动力学分析:分布容积
J Pharm Pharm Sci. 2015;18(3):515-27. doi: 10.18433/j3xc7s.
6
Quantitative Structure - Pharmacokinetics Relationships for Plasma Protein Binding of Basic Drugs.碱性药物血浆蛋白结合的定量构效关系-药代动力学关系
J Pharm Pharm Sci. 2017;20(1):349-359. doi: 10.18433/J33633.
7
A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human.一种用于预测人体药物分布容积的混合判别分析-随机森林计算模型。
J Med Chem. 2006 Apr 6;49(7):2262-7. doi: 10.1021/jm050200r.
8
Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state.使用多元回归分析从动物数据和分子结构参数预测人体药代动力学:稳态分布容积
J Pharm Pharmacol. 2003 Jul;55(7):939-49. doi: 10.1211/0022357021477.
9
Quantitative Structure - Pharmacokinetic Relationships for Plasma Clearance of Basic Drugs with Consideration of the Major Elimination Pathway.考虑主要消除途径的碱性药物血浆清除率的定量构效关系
J Pharm Pharm Sci. 2017;20(0):135-147. doi: 10.18433/J3MG71.
10
Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.开发一种预测基本药物稳态人体分布容积的新方法,并与现有方法进行比较评估。
J Pharm Sci. 2009 Dec;98(12):4941-61. doi: 10.1002/jps.21759.

引用本文的文献

1
Novel Indole-Based Sulfonylhydrazones as Potential Anti-Breast Cancer Agents: Synthesis, In Vitro Evaluation, ADME, and QSAR Studies.新型吲哚基磺酰腙类化合物作为潜在的抗乳腺癌药物:合成、体外评价、药物代谢动力学及定量构效关系研究
Pharmaceuticals (Basel). 2025 Aug 20;18(8):1231. doi: 10.3390/ph18081231.
2
Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation.具有抗癌活性和选择性的水杨醛苯甲酰腙:设计、合成及体外评价
Molecules. 2025 Feb 22;30(5):1015. doi: 10.3390/molecules30051015.
3
Development of a predictive algorithm for the efficacy of half-life extension strategies.
半衰期延长策略疗效预测算法的开发。
Int J Pharm. 2024 Jul 20;660:124382. doi: 10.1016/j.ijpharm.2024.124382. Epub 2024 Jun 23.
4
Design, Synthesis and Cytotoxic Activity of Novel Salicylaldehyde Hydrazones against Leukemia and Breast Cancer.新型水杨醛腙类化合物的设计、合成及对白血病和乳腺癌的细胞毒活性研究。
Int J Mol Sci. 2023 Apr 16;24(8):7352. doi: 10.3390/ijms24087352.
5
Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships.新型芳基磺酰基腙类化合物作为乳腺癌治疗药物的定量构效关系研究。
Molecules. 2023 Feb 22;28(5):2058. doi: 10.3390/molecules28052058.
6
How effective are ionization state-based QSPKR models at predicting pharmacokinetic parameters in humans?基于荷质比的 QSPKR 模型在预测人体药代动力学参数方面的效果如何?
Mol Divers. 2023 Aug;27(4):1675-1687. doi: 10.1007/s11030-022-10520-7. Epub 2022 Oct 11.
7
Methods to Predict Volume of Distribution.预测分布容积的方法。
Curr Pharmacol Rep. 2019 Oct;5(5):391-399. doi: 10.1007/s40495-019-00186-5. Epub 2019 Jun 6.
8
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors.金雀花碱-姜黄素杂合体作为双位点结合乙酰胆碱酯酶抑制剂。
Molecules. 2020 Jul 23;25(15):3341. doi: 10.3390/molecules25153341.
9
Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.利用微粒体分配预测组织-血浆分配系数:纳入基于生理的药代动力学模型和稳态分布容积预测。
Drug Metab Dispos. 2019 Oct;47(10):1050-1060. doi: 10.1124/dmd.119.087973. Epub 2019 Jul 19.
10
Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database.通过基于对接的ZINC数据库筛选获得的新型乙酰胆碱酯酶抑制活性命中物。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):768-776. doi: 10.1080/14756366.2018.1458031.